Eligi
Med
Ensayos clínicos
Suscripción
Sobre EligiMed
Ensayos Clínicos de Oftalmología | EligiMed
Ensayos clínicos
8.676 ensayos encontrados
Completado
Fase 1
ClinicalTrials.gov
A Randomized, Double-blind, Parallel Groups, Phase 1 Clinical Study Comparing the Pharmacokinetic, Safety and Immunogenicity of Adalimumab in Healthy Subjects
INTERVENTIONAL
Inicio: 1 de ago de 2022
ID: NCT06291948
Completado
ClinicalTrials.gov
LUMINOUS: Study to Observe the Effectiveness and Safety of Ranibizumab Through Individualized Patient Treatment and Associated Outcomes
OBSERVATIONAL
Inicio: 1 de mar de 2011
ID: NCT01318941
Completado
ClinicalTrials.gov
A Clinical Study to Evaluate the Safety and Feasibility of the OcuDyne System in the Treatment of Age-Related Macular Degeneration (AMD)
INTERVENTIONAL
Inicio: 27 de feb de 2023
ID: NCT05091476
Completado
Fase 3
ClinicalTrials.gov
A 24-month, Phase IIIb, Randomized, Double-masked, Multicenter Study Assessing the Efficacy and Safety of Two Treatment Regimens of 0.5 mg Ranibizumab Intravitreal Injections Guided by Functional and/or Anatomical Criteria, in Patients With Neovascular Age-related Macular Degeneration
INTERVENTIONAL
Inicio: 3 de jun de 2013
ID: NCT01780935
Terminado
Fase 3
ClinicalTrials.gov
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Subjects With Non-infectious Intermediate, Posterior, or Pan-uveitis Currently Controlled With Systemic Treatment
INTERVENTIONAL
Inicio: 1 de oct de 2012
ID: NCT01747538
Terminado
ClinicalTrials.gov
A Multicenter, Prospective Epidemiologic Study of the Progression of Geographic Atrophy Secondary to Age-Related Macular Degeneration
OBSERVATIONAL
Inicio: 30 de mar de 2015
ID: NCT02399072
Completado
Fase 3
ClinicalTrials.gov
A Phase III, Multicenter, Randomized, Double-Masked, Active Comparator-Controlled Study to Evaluate the Efficacy and Safety of Faricimab in Patients With Neovascular Age-Related Macular Degeneration (LUCERNE)
INTERVENTIONAL
Inicio: 11 de mar de 2019
ID: NCT03823300
Completado
Fase 2
ClinicalTrials.gov
A 2-part Study Consisting of an Open-label Multiple Ascending Dose (MAD) Safety Study, and a Dose-finding Single-masked Comparative Safety and Preliminary Efficacy Study of Intravitreal (IVT) EYE103 in a Mixed Population of Participants With Diabetic Macular Edema (DME) or Neovascular Age-related Macular Degeneration (NVAMD)
INTERVENTIONAL
Inicio: 12 de jun de 2023
ID: NCT05919693
Terminado
ClinicalTrials.gov
A Multicenter, Prospective Epidemiologic Study of The Progression of Geographic Atrophy Secondary to Age-Related Macular Degeneration
OBSERVATIONAL
Inicio: 24 de jun de 2015
ID: NCT02479386
Completado
Fase 3
ClinicalTrials.gov
The Efficacy and Safety of Bimatoprost SR in Patients With Open-angle Glaucoma or Ocular Hypertension
INTERVENTIONAL
Inicio: 15 de dic de 2014
ID: NCT02250651
Completado
Fase 3
ClinicalTrials.gov
A Phase 3 Multicenter, Randomized, Double Masked, Sham- Controlled Clinical Trial to Assess the Safety and Efficacy of Intravitreal Administration of Zimura (Complement C5 Inhibitor) in Patients With Geographic Atrophy Secondary to Age-Related Macular Degeneration
INTERVENTIONAL
Inicio: 22 de jun de 2020
ID: NCT04435366
Completado
Fase 3
ClinicalTrials.gov
Clinical Study for Evaluating the Safety and Clinical Effectiveness of Intravitreal Bevacizumab (Lumiere®) in Patients With Wet Age-related Macular Degeneration.
INTERVENTIONAL
Inicio: 7 de feb de 2017
ID: NCT03668054
Terminado
Fase 3
ClinicalTrials.gov
A Phase III, Multicenter, Randomized, Double-Masked, Sham-Controlled Study to Assess the Efficacy and Safety of Lampalizumab Administered Intravitreally to Patients With Geographic Atrophy Secondary to Age-Related Macular Degeneration
INTERVENTIONAL
Inicio: 18 de sept de 2014
ID: NCT02247479
Terminado
Fase 2
ClinicalTrials.gov
A Study to Evaluate Safety and Efficacy of KPI-012 Ophthalmic Solution in Participants With Persistent Corneal Epithelial Defect (PCED)
INTERVENTIONAL
Inicio: 7 de feb de 2023
ID: NCT05727878
Activo, no recluta
Fase 3
ClinicalTrials.gov
An Extension Trial to Evaluate the Long-term Safety and Efficacy of Bimatoprost SR in Patients With Open Angle Glaucoma or Ocular Hypertension
INTERVENTIONAL
Inicio: 27 de mar de 2019
ID: NCT03891446
Completado
Fase 3
ClinicalTrials.gov
Safety and Efficacy of Abicipar Pegol (AGN-150998) in Patients With Neovascular Age-related Macular Degeneration (CEDAR Study)
INTERVENTIONAL
Inicio: 25 de jun de 2015
ID: NCT02462928
Completado
ClinicalTrials.gov
Evaluation of an eXtended and proacTive Dosing regimEn in Treatment-Naïve Patients With Wet Age-related Macular Degeneration (wAMD)
OBSERVATIONAL
Inicio: 12 de may de 2019
ID: NCT03939767
Terminado
Fase 3
ClinicalTrials.gov
A Phase 3 Randomized, Double-masked, Controlled Trial to Establish the Safety and Efficacy of Intravitreous Administration of Fovista® (Anti PDGF-B Pegylated Aptamer) Administered in Combination With Lucentis® Compared to Lucentis® Monotherapy in Subjects With Subfoveal Neovascular Age-related Macular Degeneration.
INTERVENTIONAL
Inicio: 1 de ago de 2013
ID: NCT01940900
Completado
Fase 3
ClinicalTrials.gov
A Randomized, Double Masked, Active Controlled, Phase 3 Study of the Efficacy, Safety, and Tolerability of Repeated Doses of Intravitreal VEGF Trap in Subjects With Neovascular Age-related Macular Degeneration (AMD)
INTERVENTIONAL
Inicio: 1 de abr de 2008
ID: NCT00637377
Completado
Fase 3
ClinicalTrials.gov
Randomized, Double-Masked, Active-Controlled, Phase 3 Study of the Efficacy and Safety of High Dose Aflibercept in Patients With Neovascular Age-Related Macular Degeneration
INTERVENTIONAL
Inicio: 11 de ago de 2020
ID: NCT04423718
Anterior
1
2
3
...
434
Siguiente
Filtros